The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Schizophrenia Care: Improving Social Cognition and Motivation
Schizophrenia Care: Improving Social Cognition and Motivation
Early Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care
Early Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
